Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Tuesday, June 30

POSER SESIN Trc B 22224-22248

22224 Disseminated histoplasmosis in AIDS patients
Liliana Puga*; A. Montecelli; G. LeviHara; R. Negroni; S. Carnovale;
H. Jauregui, Argentina
22225 Conditioning factors of mortality from cryptococcosis
Aldo Maranzana*; A. Thwaites; G. Prada; 0. GarciaMessina; 6. Ortega;
O.M. Bases;J. Benetucci, Argentina
22226 Amphotericin combined with itraconazole is superior to amphotericin
alone in cryptococcal meningitis
Somsit Tansuphasawadikul, Thailand
22227 Clinical manifestation of AIDS-associated histoplasmosis in Uruguay
Mariela Mansilla*; A.D. Dutra da Silveira; H.N. Laca; R. Balleste;
A.T. Braselli, Uruguay
22228 Acute disseminated histoplasmosis and pneumocystis carinii pneumonia
in a patient with AIDS
Marcelo Corti*; P. Esquivel; M. Villafane; I. Soto; R. Masini, Argentina
22229 Opportunistic fungal infections in HIV/AIDS patients
Aza Rakhmanova*; O.H. Gyaurgieva; E.I. Romanova; G.M. Gurkalo;
V.K. Prigozhina; N.N. Vlasov; N.A. Chaika, Russia
22230 A powerful DNA-extraction method and polymerase chain reaction for
detection of microsporidia in clinical stool specimens
Caspar Franzen*; Andreas M/ller; K. Stellermann; P. Hartmann;
G. Fdtkenheuer; B. Salzberger; V. Diehl; C Franzen, Germany
22231 Long-term serologic study of toxoplasmosis in HIV patients
Alberto Delgado-lribarren*;J. Gomez; M. Alamo; A.F. Perez; A. Arribi;
M.T. Calvo, Spain
22232 Efficacy and safety of intermittent oral fumagillin for the treatment of
enterocytozoon bieneusi infections in patients with AIDS (ANRS 054)
Jean-MichelMolina*;J. Goguel; C. Sarpati;J.F. Michiels;
I. Desportes-Livage; C.L. Chastang; L. Cotte, France
22233 Intestinal microsporidiosis as a waterborn disease: Report of an
outbreak in HIV-infected and non-infected patients
Laurent Cotte; M. Rabodonirina; F. Chapuis; C. Raynal; F. Bissuel;
I. Schlienger; C. Trepo, France
22234 Incidence and risk factors oftoxoplasmosis in a French cohort of HIVinfected patients between 1988 and 1995
Francois Belanger; Francis Derouin; L. Grangeot-Keros; L. Meyer, France
22235 Determination of genotypes of enterocytozoon bieneusi strains isolated
from patients with intestinal microsporidiosis
Olivier Liguory*; F. David; F. Derovin;J.M. Molina, France
22236 Falciparum malaria and its association with immune status in a cohort
of HIV-1 infected adults in
Neil French*; E. Lugadda; C. Watera; J. Nakiyingi; L. Carpenter; C.F. Gilks,
Uganda
22237 Sustained disappearance of human cytomegalovirus (HCMV) in blood
of AIDS patients following HAART
Giuseppe Gerna*; F. Baldanti; A. D'Arminio Monforte; M. Zavattoni;
R. Maserati; L. Testa; G. Gorini, Italy
22238 Lack of effect of long-term HAART on hepatitis C (HCV) viremia
Olivier T. Rutschmann*; B. Hirschel; F. Negro; L.H. Perrin, Switzerland

22239 Recurrence of CMV disease in patients with a history of CMV retinitis
receiving protease inhibitors
Dominique Salmon*; Dominique Costagliola; Dominique Salmon; C.
Michon; C. Katlama;J.M. Lang; J. Gerbe, France

22240 Evidence that HAART induced immune recovery vitritis in CMV retinitis
patients is immune mediated
Francesca Torriani*; W. Freeman; D. Durand; M. Karavellas;
R. Schrier, USA
22241 Predictive value of cytomegalovirus (CMV)-PCR and pp-65 for the
detection of CMV-disease in AIDS-patients (pts.) in the era of HAART
AlbrechtStoehr*; T. Fenner; C. Mocklinghoff, T. Lorenzen; A. Plettenberg,
Germany
22242 Long-term response to interferon therapy in HIV-infected patients with
chronic hepatitis C
Vincent Soriano*, Javier Garcia-Samaniego; Mayte Perez-Olmeda;
Soledad Lopez-Calvo; Angeles Castro; Juan Gonzalez; V. Soriano;
J. Gonzalez-Lahoz, Spain
22243 Rapidly evolving hepatitis-C virus infection in HIV coinfected patients
treated with HAART
Gilles Pialoux*; A. Landau; M. Eliaszewicz; S. Pol; F. Carnot;J.D. Poveda;
B. Dupont, France
22244 Long lasting remission of cytomegalovirus retinitis (CMV-R) without
maintenance therapy in HIV-infected patients
Cristina Tural*;J. Romeu; G. Sirera; D. Andreu; L. Ruiz; A. Arno;
B. Clotet, Spain
22245 Safety profile of low (3.0 mg/ml) and high (6.6 mg/ml) dose fomivirsen
for the treatment of CMV retinitis
RonniM. Lieberman*; L.R. Grillone; J.W. Chandler, USA
22246 A comparison of four assays for CMV viremia in patients with AIDS at
risk for CMV end-organ disease
David Wohl*; C. Noetzel; S.A. Fiscus; T. Alcorn; S.M. Scheiber; J. Handy;
C. Van der Horst, USA
22247 Ganciclovir resistance in a prospective cohort of HIV-infected patients
with cytomegalovirus (CMV) retinitis
Christine Jacomet*; C. Taslo; N. Aissa; N. Delphin; E. Wirbel;J.C. Nicolas;
W. Rozenbaum, France
22248 Cytomegalovirus (CMV) blood dissemination in HIV-infected patients
(Predivir Cohort):Value of different CMV blood markers in predicting
occurence of CMV disease
Marie-Christine Mazeron*; D. Costagliola; D. Salmon; A.M. Fillet;
N. Houhou;J. Gozlan; F Freymuth, France
NOTES

IUNE

CONFERENCE WORKBOOK

87